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Abstract
Background: Exercise-induced improvements in cardiorespiratory fitness (CRF) often coincide with improvements
in insulin sensitivity and reductions in liver fat content. However, there are limited data concerning the relationship
between CRF and liver fat content in adults with varying degrees of metabolic dysfunction.
Methods: The aim of this study was to examine the association between CRF, liver fat content, and insulin
resistance in inactive adults with obesity and with or without type 2 diabetes (T2D), via cross-sectional analysis. CRF
was determined via a graded exercise test. Liver fat content was assessed via proton magnetic resonance
spectroscopy and insulin resistance was assessed via homeostatic model of insulin resistance (HOMA-IR). A partial
correlation analysis, controlling for age and gender, was performed to determine the association between CRF,
demographic, cardiometabolic, and anthropometric variables. Independent t tests were performed to
compare cardiometabolic outcomes between participants with T2D and participants without T2D.
Results: Seventy-two adults (46% male) with a mean age of 49.28 ± 10.8 years, BMI of 34.69 ± 4.87 kg/m2, liver fat
content of 8.37 ± 6.90%, HOMA-IR of 3.07 ± 2.33 and CRF of 21.52 ± 3.77mL/kg/min participated in this study. CRF was
inversely associated with liver fat content (r = − 0.28, p = 0.019) and HOMA-IR (r = − 0.40, p < 0.001). Participants with T2D
had significantly higher liver fat content (+ 3.66%, p = 0.024) and HOMA-IR (+ 2.44, p < 0.001) than participants without
T2D. Participants with T2D tended to have lower CRF than participants without T2D (− 1.5ml/kg/min, p= 0.094).
Conclusion: CRF was inversely associated with liver fat content and insulin resistance. Participants with T2D had lower
CRF than those without T2D, however, the difference was not statistically significant. Further longitudinal studies are
required to elucidate the relationship between CRF and the progression of obesity-related diseases such as T2D.
Registration: ACTRN12614001220651 (retrospectively registered on the 19th November 2014) and ACTRN12614000723684
(prospectively registered on the 8th July 2014).
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Background
Obesity plays a significant role in the development of
many chronic diseases such as hypertension, coronary
heart disease, numerous cancers, and type 2 diabetes
(T2D) [48]. While the relationship between obesity and
increased cardiometabolic risk is well established [1], the
location of adipose tissue, particularly in and/or around
the liver, heart, muscles, and pancreas, also known as
ectopic fat, is significantly more predictive of adverse
health outcomes such as hypertension and hypergly-
caemia [36]. Metabolic dysfunction-associated fatty
liver disease (MAFLD), characterised by excessive
liver fat (LF) content, is strongly associated with insu-
lin resistance and is highly prevalent in individuals
with T2D [41]. As T2D and MAFLD share a similar
underlying pathological process, they often present
alongside other disorders such as obesity, dyslipidae-
mia, and hypertension [49]. A known strategy for
managing these risk factors is increased physical ac-
tivity [23, 43], which importantly leads to improved
cardiorespiratory fitness (CRF) [8]. However, individ-
uals with T2D and/or MAFLD reportedly experience
disease-related aerobic impairments, which contribute
to, or are further affected by, mitochondrial dysfunc-
tion, cardiac dysfunction, insulin resistance, and dia-
stolic dysfunction - which may manifest as low CRF
[6, 44].
Low CRF is a well-established risk factor for all-cause
morbidity and mortality [18] and increases an individ-
ual’s risk for developing T2D [40]. Multiple studies
have shown that individuals who engage in structured
exercise can improve CRF, insulin sensitivity, and re-
duce ectopic fat [13, 29–31], however, it is unclear
whether these improvements are mediated through
changes in CRF or through simply undertaking regu-
lar exercise. Recent observational data have shown
that while physical activity levels were not associated
with LF [16], low CRF was strongly and independ-
ently associated with MAFLD prevalence [9]. How-
ever, these findings are yet to be confirmed in
participants with varying T2D-status using gold-
standard LF quantification techniques and maximal
exercise tests to determine CRF.
Decoupling CRF from physical activity-related im-
provements has proven difficult due to the interrelated
nature of the two measures [24]. It could therefore be
assumed that individuals who have higher physical activ-
ity and CRF levels also partake in other healthy behav-
iours, which provide further protection from a variety of
obesity-related complications [34]. Furthermore, it is be-
coming increasingly accepted that both modifiable ,such
as physical activity levels, and non-modifiable factors,
such as gene-specific variations, contribute to variations
in CRF [5, 33], with the relative genetic contribution to
CRF reported to be ~ 50% [3, 33]. Consequently, it is im-
portant to explore the association between CRF and car-
diometabolic risk in adults with similar levels of self-
reported physical activity in order to decouple physical
activity from CRF and better assess CRF-related benefits
independently. There are limited studies which have in-
vestigated the relationship between CRF and insulin re-
sistance in adults with and without T2D, and even fewer
studies assessing the relationship between CRF and LF,
as quantified via gold-standard proton magnetic spec-
troscopy (1H-MRS). Therefore, the aim of this cross-
sectional study, was to determine the association be-
tween CRF, LF, insulin resistance, and other cardiometa-
bolic outcomes in inactive adults with obesity, and with
or without T2D. A secondary aim was to compare car-
diometabolic and CRF differences between adults with
T2D to those without T2D. It was hypothesised that
CRF would be inversely associated with LF content and
insulin resistance. It was also hypothesised that inactive
adults with obesity and T2D would have significantly




The participants of this study were recruited via elec-
tronic bulletins, clinical databases, and media advertise-
ments between June 2011 and February 2019. Eligible
volunteers were between the ages of 18–65 years, had a
BMI ≥ 30.0 kg/m2, self-reported being physically inactive
(exercising < 3 days/week) and/or not currently meeting
physical activity guidelines [4]. All participants were
screened by a medical practitioner prior to enrolment
and were excluded if there was evidence of an unstable
cardiac condition, uncontrolled hypertension, or uncon-
trolled blood glucose. The analysis included 72 volunteers
from two larger intervention trials (ACTRN12614001220651
and ACTRN12614000723684) for which the results
have been published elsewhere [14, 31, 46]. Eligible
participants were screened via telephone interview and
those who met the inclusion criteria and provided
written informed consent, were enrolled in the study
and were assessed at the University of Sydney (NSW,
Australia). The study conformed to the ethical guidelines
of the 1975 Declaration of Helsinki and the procedures
were approved by the University of Sydney Human
Research Ethics Committee.
Anthropometry and blood pressure assessment
Relevant anthropometric data were collected in accord-
ance with international standards [38]. The height of the
participants was measured via stadiometer (SECA model
220 Telescopic Height Rod, Hamburg, Germany). Partic-
ipants body weight was measured using Tanita BC-418
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Body Composition Analyzer (Tanita Corporation, Tokyo,
Japan) to the nearest 0.1 kg and BMI (kg/m2) was
calculated. Waist circumference (WC) was measured
(SECA Model 201, Hamburg, Germany) thrice horizon-
tally, between the inferior margin of the ribs and the su-
perior border of the iliac crest after expiration but before
inspiration. After 10 to 15 mins of quiet sitting, systolic
(SBP) and diastolic (DBP) blood pressures were measured
manually on each arm with a sphygmomanometer (Welch
Allyn® 767 Series Aneroid; New York, USA) and the
average of three measures was recorded from the arm
which produced the highest SBP and DBP readings.
Biochemical parameters
Venous blood was collected after an overnight fast (>
10 h) for the purpose of determining fasting blood
glucose (FBG), insulin, high-sensitivity C-reactive pro-
tein (CRP), total cholesterol (TC), triglycerides (TG),
high-density lipoprotein cholesterol (HDL), low-
density lipoprotein cholesterol (LDL), alanine amino-
transferase (ALT), and aspartate aminotransferase
(AST). Concentration of plasma free fatty acids (FFA)
was measured using stored plasma. All biochemical
and lipid assessments were completed by a private
accredited laboratory. Insulin resistance was assessed
via the homeostatic model of insulin resistance
(HOMA-IR) [45].
Proton magnetic resonance spectroscopy (1H-MRS)
LF% was measured via 1H-MRS using a Phillips Intera
1.5 Telsa Achieva MRI system (Philips Medical Systems,
Best, Netherlands). Spectral data were post-processed by
an assessor (NAJ), who was blinded to participant de-
tails, using a magnetic resonance user interface software
(jMRUI, version 5.2; www.jmrui.eu) [25, 37]. LF% ≥ 5.5%
was considered consistent with the presence of meta-
bolic dysfunction-associated fatty liver disease (MAFLD)
[39]. The LF% quantification methodology employed in
this study is comprehensively detailed elsewhere [31].
Cardiorespiratory fitness
CRF was assessed via a graded maximal exercise test on
an electronically-braked cycle ergometer (Lode Corival,
Netherlands) under the supervision of an Accredited Ex-
ercise Physiologist [35]. All tests incorporated a three-
min warm up at 35W and 65W for women and men,
respectively, and workloads were incrementally adjusted
by 25W every 150 s until volitional fatigue as described
elsewhere [15]. Heart rate, blood pressure, and ratings of
perceived exertion (RPE) were obtained at each stage of
exercise, with RPE measured using the Borg scale [2].
The test was terminated when the pedalling rate fell
below 50 revolutions per min despite encouragement, or
volitional fatigue. Peak work capacity (Wpeak) was
measured [20] and peak oxygen consumption (VO2Peak)
estimated as described previously [10]. CRF was assessed
within one-week of LF assessment.
Statistical analysis
Data were analysed using Statistical Package for the Social
Sciences (SPSS version 24.0; IBM Corp., Armonk, NY,
USA). All data are reported as the mean values ± standard
deviation (SD) unless otherwise stated. Independent t tests
were performed to compare differences in CRF and other
biochemical and anthropometric measures between indi-
viduals with and without T2D. Homogeneity of variances
was assessed via Levene’s test for equality of variance and
χ2 for categorical data. Abnormally distributed primary
outcome measures were transformed via natural logarithm
prior to between-group comparisons. Partial correlation
coefficients (r), controlling for age and sex, were used for
correlations between continuous variables, and where one
of the variables was dichotomous categorical data and the
other was continuous. Associations between two categor-
ical variables were assessed by χ2 test for independence,
whereby the φ coefficient determined the magnitude of
the correlation. The magnitude of correlations were quali-
tatively assessed as: trivial (r < 0.1), small (r > 0.1 to 0.3),
moderate (r > 0.3 to 0.4), strong (r > 0.5 to 0.7), very strong
(r > 0.7 to 0.9), nearly perfect (r > 0.9), and perfect (r = 1.0)
[11]. Male and female participants were divided into CRF
quartiles, respectively, and analysis of variance was
employed to determine significant differences in cardio-
metabolic outcomes between CRF quartiles (lowest fitness,
IQR, highest fitness). Least significant difference post-hoc
comparisons were used to identify and compare signifi-
cant differences between CRF quartiles. Effect sizes were
calculated as standardised difference in the means and
expressed as Cohen’s d. Statistical significance was set at
p < 0.05. A two-tailed sensitivity analysis using the effect
size of the difference in LF content between participants
with T2D versus participants without T2D revealed that
the study achieved 78% power (G-Power software; Univer-
sity of Trier, Trier, Germany).
Results
Participants
Participant characteristics are summarised in Table 1. A
total of 72 (33 male and 39 female) volunteers participated
in this study. The mean age was 49.28 ± 10.18 years, BMI
34.69 ± 4.87 kg/m2, WC 108.55 ± 14.43 cm, LF was 8.37 ±
6.90%, and CRF was 21.52 ± 3.77ml/kg/min. The preva-
lence of MAFLD was 43% in participants without T2D ,
65% in participants with T2D, and 54% amongst all partic-
ipants. Participants with T2D had significantly higher
WC, LF%, HOMA-IR, FBG, ALT, TC, HDL, LDL, and
FFA than those without T2D (p < 0.05 for all). There were
no differences in other variables between participants with
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or without T2D. Male participants had significantly higher
WC, TC, HDL, LDL, CRP, HOMA-IR and SBP than fe-
male participants (Supplementary Table 1).
Partial correlations
The associations between CRF, demographic, anthropo-
metric, and cardiometabolic variables are summarised in
Table 2. CRF was inversely associated with LF% (r = −
0.271), HOMA-IR (r = − 0.411), BMI (r = − 0.527), WC
(r = − 0.490), FFA (r = − 0.283), CRP (r = − 0.344) FBG
(r = − 0.259), insulin (r = − 0.403), and SBP (r = − 0.292)
(p < 0.05 for all).
CRF and cardiometabolic outcomes
Participant characteristics stratified by CRF are sum-
marised in Table 3. Participants with the lowest CRF had
significantly higher LF% and HOMA-IR than those with
the highest CRF (+ 5.31%, p = 0.021, + 2.50, p = 0.001,
respectively) (Fig. 1). When compared to participants with
the highest CRF, those with the lowest CRF also had signifi-
cantly higher BMI (+ 7.54 kg/m2, p < 0.001), WC (+ 18.65
cm, p < 0.001), CRP (+ 3.80mg/L, p = 0.012), FBG (+ 2.06
mmol/L, p = 0.034), insulin (+ 5.57mU/L, p = 0.008), FFA
(+ 153.34 umol/L, p = 0.015), and SBP (+ 16.57mmHg, p =
0.001). When compared to participants with CRF scores
within the interquartile range, those with the lowest CRF
had significantly higher BMI (+ 7.54 kg/m2, p < 0.001), WC
(+ 18.65 cm, p < 0.001), CRP (+ 3.93mg/L, p = 0.003) and
SBP (+ 10.89mmHg, p = 0.014).
Discussion
This study is one of the first to show significant associations
between key cardiometabolic risk factors, such as LF con-
tent, quantified via gold-standard 1H-MRS, and CRF in in-
dividuals with and without T2D. The analyses showed that
the prevalence of MAFLD in participants with T2D was
Table 1 Participant characteristics
Normal Glucose
Tolerance (n = 37)
Type 2 Diabetes
(n = 35)
Total (n = 72) p ES (95%CI)
Demographics and anthropometry
Gender (M/F) 13/24 20/15 33/39 0.610
MAFLD (Y/N) 16/21 23/12 39/33 0.056
Age (years) 44.84 (10.23) 53.97 (7.85) 49.28 (10.18) <0.001 -1.030 (-3.93 to 1.86)
Waist Circumference (cm) 101.21 (12.30) 116.30 (12.43) 108.55 (14.43) <0.001 -1.26 (-5.18 to 2.67)
BMI (kg/m2) 33.62 (4.52) 35.81 (5.04) 34.69 (4.87) 0.056 -0.47 (-1.99 to 1.05)
LF (%) 6.59 (5.93) 10.25 (7.43) 8.37 (6.90) 0.008 -0.65 (-0.84 to -0.45)
SBP (mmHg) 122.92 (14.41) 129.41 (16.85) 126.07 (15.87) 0.083 -0.43 (-5.40 to 4.55)
DBP (mmHg) 79.30 (6.99) 80.16 (9.28) 79.71 (8.14) 0.658 -0.11 (-2.72 to 2.50)
Biochemistry
AST (U/L) 22.32 (9.17) 29.06 (21.05) 25.60 (16.32) 0.080 -0.43 (-5.58 to 4.73)
ALT (U/L) 22.95 (10.13) 35.17 (23.10) 28.89 (18.59) 0.005 -0.71 (-6.37 to 4.95)
CRP (mg/L) 4.65 (4.71) 4.11 (4.73) 4.39 (4.70) 0.628 0.12 (-1.38 to 1.62)
FBG (mmol/L) 4.28 (0.61) 8.21 (3.00) 6.19 (2.90) <0.001 -1.87 (-2.56 to 1.18)
aInsulin (mU/L) 10.22 (5.96) 12.17 (6.63) 11.08 (6.29) 0.212 -0.32 (-2.32 to 1.68)
aHOMA-IR 2.00 (1.34) 4.43 (2.61) 3.07 (2.33) <0.001 -1.21 (-1.86 to -0.55)
Lipids
Triglycerides (mmol/L) 1.49 (0.86) 1.66 (0.67) 1.57 (0.78) 0.368 -0.23 (-0.47 to 0.02)
Total Cholesterol (mmol/L) 5.59 (1.25) 4.43 (0.80) 5.03 (1.20) <0.001 1.14 (0.80 to 1.47)
HDL (mmol/L) 1.40 (0.32) 1.15 (0.26) 1.28 (0.32) 0.001 0.88 (0.79 to 0.98)
LDL (mmol/L) 3.53 (0.95) 2.47 (0.75) 3.02 (1.01) <0.001 1.27 (1.00 to 1.55)
FFA (umol/L) 389.67 (162.24) 508.71 (198.24) 447.54 (189.09) 0.007 -0.68 (-58.18 to 56.83)
Cardiorespiratory Fitness
VO2peak (mL/kg/min) 22.24 (3.90) 20.75 (3.51) 21.52 (3.77) 0.094 0.41 (-0.77 to 1.59)
Data presented as mean (SD). ES effect size, CI confidence interval, M male, F female, MAFLD metabolic dysfunction-associated fatty liver disease, Y yes, N no, BMI
body mass index, LF% liver fat percentage, SBP systolic blood pressure, DBP diastolic blood pressure, AST aspartate aminotransferase, ALT alanine
aminotransferase, CRP high-sensitivity C-reactive protein, FBG fasting blood glucose, HOMA-IR homeostatic model assessment of insulin resistance, HDL high-
density lipoprotein cholesterol, LDL low-density lipoprotein cholesterol, FFA free fatty acids, VO2peak Peak oxygen consumption.
aHOMA-IR and insulin measures
reported for 37 participants with normal glucose tolerance and 29 participants with T2D as 6 participants with T2D were undergoing exogenous insulin therapy
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65%, which is consistent with previous reports [50]. When
compared to participants without T2D, those with T2D
had significantly higher cardiometabolic abnormalities. Fur-
thermore, adults with T2D also had lower CRF than those
without T2D, however, the difference was not statistically
significant. Further analyses showed that even relatively
small variations in CRF were associated with increased
LF content and insulin resistance, which were significantly
higher in individuals with relatively low CRF than those
with relatively high CRF. Similarly, individuals with the
highest CRF had lower cardiometabolic and inflammatory
abnormalities than those with the lowest CRF.
The association between cardiorespiratory fitness and
liver fat
In accordance with the original hypothesis, CRF was
inversely associated with LF content. This finding sup-
ports previously reported data, where Kantartzis and
colleagues showed that LF content was inversely asso-
ciated with CRF (r = − 0.22, p = 0.005) in a mixed sam-
ple of adults with MAFLD or adults at risk of
metabolic disease [12]. Similarly, the findings from
The Young Finns study showed that for every 1 ml/kg/
min increase in CRF, the risk of MAFLD significantly
declined (risk ratio = 0.90, 95% confidence interval 0.88
to 0.93; p < 0.001), however, LF content was measured
up to three years after initial assessment of CRF and
done so using ultrasound, which is less accurate than
1H-MRS [27]. Another study reported low CRF was
inversely associated with increasing MAFLD activity
and steatohepatitis severity measured via liver biopsy
and sampled up to four months after CRF assessment
[19]. The results of the study reported herein add to
previous findings and suggest that even relatively small
variations in CRF are associated with increased LF in
inactive adults with or at risk of T2D. Importantly, the
Table 3 Participant characteristics when stratified by cardiorespiratory fitness
Lowest Fitness, n = 18
(16.71 ml/kg/min)
IQR, n = 36
(21.49 ml/kg/min)
Highest Fitness, n = 18
(26.36 ml/kg/min)
Between group p ES (95%CI)
Demographics and anthropometry
Gender (M/F) 8/10 17/19 8/10 0.974
Type 2 Diabetes (Y/N) 11/7 18/18 6/12 0.250
MAFLD (Y/N) 15/3 16/20 8/10 0.015 b, c
Age (years) 54.56 (9.94) 47.33 (9.48) 47.89 (10.47) 0.037 b, c 0.67 (-2.57 to 3.91)
Waist Circumference (cm) 119.03 (15.38) 107.39 (12.64) 100.38 (10.70) <0.001 b, c 1.45 (-2.76 to 5.65)
BMI (kg/m2) 39.81 (4.29) 33.34 (3.55) 32.27 (4.12) <0.001 b, c 1.85 (0.51 to 3.18)
LF (%) 11.40 (6.25) 8.00 (7.48) 6.08 (5.40) 0.033 b 0.94 (-0.92 to 2.79)
SBP (mmHg) 135.66 (20.17) 124.77 (13.08) 119.09 (11.86) 0.004 b, c 1.03 (-4.22 to 6.28)
DBP (mmHg) 83.21 (11.33) 78.60 (6.58) 78.44 (6.46) 0.107 b 0.53 (-2.40 to 3.46)
Biochemistry
AST (U/L) 30.39 (22.57) 25.78 (16.16) 20.44 (3.62) 0.189 0.633 (-4.50 to 5.77)
ALT (U/L) 34.72 (22.72) 29.22 (18.81) 22.39 (10.82) 0.136 b 0.71 (-4.94 to 6.36)
CRP (mg/L) 7.30 (6.72) 3.38 (3.41) 3.51 (3.30) 0.008 b, c 0.74 (-0.94 to 2.42)
FBG (mmol/L) 7.14 (3.16) 6.26 (3.14) 5.01 (1.59) 0.101 b 0.88 (0.08 to 1.67)
aInsulin (mU/L) 14.29 (7.79) 10.68 (6.16) 8.72 (3.37) 0.026 b 0.96 (-0.95 to 2.86)
aHOMA-IR 4.56 (2.89) 2.82 (2.06) 2.08 (1.44) 0.004 b, c 1.12 (0.39 to 1.84)
Lipids
Triglycerides (mmol/L) 1.61 (0.75) 1.57 (0.73) 1.54 (0.91) 0.973 0.09 (-0.18 to 0.35)
Total Cholesterol (mmol/L) 4.93 (1.34) 4.93 (1.24) 5.30 (0.95) 0.527 -0.33 (-0.70 to 0.04)
HDL (mmol/L) 1.30 (0.30) 1.22 (0.34) 1.38 (0.29) 0.223 -0.28 (-0.37 to -0.19)
LDL (mmol/L) 2.88 (1.10) 2.96 (1.03) 3.27 (0.87) 0.464 -0.41 (-0.72 to -0.09)
FFA (umol/L) 531.83 (196.93) 439.92 (188.65) 378.49 (156.79) 0.047 b 0.89(-55.62 to 57.39)
Data presented as mean (SD). IQR interquartile range, ES effect size, CI confidence interval, M male, F female, MAFLD metabolic dysfunction-associated fatty liver
disease, Y yes, N no, BMI body mass index, LF% liver fat percentage, SBP systolic blood pressure, DBP diastolic blood pressure, AST aspartate aminotransferase, ALT
alanine aminotransferase, CRP high-sensitivity C-reactive protein, FBG fasting blood glucose, HOMA-IR homeostatic model assessment of insulin resistance, HDL
high-density lipoprotein cholesterol, LDL low-density lipoprotein cholesterol, FFA free fatty acids, VO2 Peak oxygen consumption.
aHOMA-IR and insulin measures
reported for 37 participants with normal glucose tolerance and 29 participants with T2D as 6 participants with T2D were undergoing exogenous insulin therapy.
bsignificant difference between lowest and highest fitness; csignificant difference between lowest fitness and IQR
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assessments of CRF and LF content were undertaken
within a narrow timeframe (< 1 week) and LF% was
quantified using gold-standard 1H-MRS, thus highlight-
ing the novelty and methodological rigour of the
present study.
The association between cardiorespiratory fitness and
insulin resistance and other cardiometabolic outcomes
In accordance with the original hypothesis, CRF was
inversely associated with insulin resistance. Further ana-
lyses revealed that, on average, individuals with relatively
poor fitness had abnormally high levels of insulin resist-
ance, blood pressure, inflammation and LF content,
whereas individuals with relatively high fitness, only
had slightly abnormal LF content (11.40% vs. 6.08% for
low vs. high CRF, respectively). These data, which are
supported by previous findings [12, 13, 22, 29–31, 47],
suggest that CRF may play an important role in the con-
text of metabolic disease.
A recent meta-analysis reported that CRF was in-
versely associated with T2D prevalence in a dose-
dependent manner [28]. The results of the current study
showed that while participants with T2D had lower CRF
than those without T2D, the difference was not statisti-
cally significant. Furthermore, as physical activity has
been shown to be inversely associated with LF content
independent of BMI [17], only inactive participants were
included in this study in an attempt to control for higher
levels of physical activity - which incur cardiometabolic
benefits. Because of this, the mean level of CRF of par-
ticipants was quite low at 21.5 mL/kg/min. Reports show
that CRF < 29.1 mL/kg/min increases the likelihood of
developing metabolic syndrome six-fold [21], conse-
quently a greater number of participants with higher
levels of CRF are required to provide more robust
results.
Mechanisms
While the mechanistic interplay between low CRF,
MAFLD, and T2D remains unclear, it is purported
that low CRF and ensuing mitochondrial defects contrib-
ute to the incomplete oxidation of fatty acids, which
contribute to the accumulation of fatty acid by-products,
such as ceramides and diacylglycerol in skeletal muscle
and liver cells. The intracellular accumulation of these
by-products impair insulin signalling pathways and con-
tribute to insulin resistance [7, 26]. Importantly, T2D-
related exercise intolerance appears to be reversed by
regular exercise, which is made evident by the ameli-
oration of skeletal muscle mitochondrial impair-
ments, as well as improved insulin sensitivity, and
CRF [29, 32, 42].
Fig. 1 Differences in liver fat content and insulin resistance between CRF quartiles. Data presented as mean (SD). ES, effect size; CI, confidence
interval; LF%, liver fat percentage; HOMA-IR, homeostatic model of insulin resistance; IQR, interquartile range. Brackets indicate
significant difference
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Strengths
This study adds to existing literature by highlighting the
importance of CRF for metabolic health in adults with
or at risk of metabolic disease. While previous studies
have shown similar findings [12, 27], this is the first
study to do so involving a mixed sample of inactive
adults with obesity and with or without T2D. Further-
more, CRF and LF were measured within a week of each
other, whereas previous studies had measured CRF up
to three years after LF assessment [27]. Finally, this
study quantified LF% using 1H-MRS, which is currently
considered the gold-standard non-invasive technique for
LF quantification.
Limitations
This study has limitations that should be considered
when interpreting the results. Firstly, the results of this
study, by nature, incorporated measures of CRF and
LF content at a time-specific point and did not track the
progression of any outcome to determine their relative
importance in the development of MAFLD or T2D dis-
ease progression. Secondly, this study was completed
using baseline data from previous interventional studies
which prevented an a priori power analysis. However,
the two-tailed sensitivity analysis revealed that the study
achieved 78% power, which is just shy of the commonly
accepted 80% value. Thirdly, this study assessed the
amount of LF% per se and the methodology employed
cannot determine the amount of fibrosis or classification
of more severe liver diseases such as non-alcoholic stea-
tohepatitis and/or their association with CRF. Addition-
ally, while 1H-MRS is currently considered the gold-
standard non-invasive measurement technique for LF%,
HOMA-IR is comparatively more limited and cannot
provide inference into tissue-specific impairments in in-
sulin sensitivity. Fourthly, although CRF was assessed
using a validated graded exercise test model [10], the
gold-standard of aerobic capacity testing involves direct
measures of gas analysis, and where possible, this
method should be implemented. Finally, while an at-
tempt was made to control for high levels of physical ac-
tivity by only recruiting individuals who reported to be
inactive (exercising < 3 days/week), inter-participant vari-
ations in physical activity levels likely contributed to the
associations between CRF and LF.
Conclusions
The results of this study showed that CRF was inversely
associated with 1H-MRS-quantified LF content in in-
active adults with obesity. CRF was also inversely associ-
ated with insulin resistance and other key
cardiometabolic risk factors. Adults with T2D had lower
CRF than adults without T2D, however, the difference
did not achieve statistical significance. These findings
suggest that CRF may play a key role in metabolic dys-
function, however, further longitudinal studies are re-
quired to elucidate the relationship between CRF and
the progression of obesity-related diseases such as
MAFLD and T2D.
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